Acne Medication Market : Eminent Players – Allergan plc, Galderma S.A., Reckitt Benckiser Group plc, Guthy-Renker, Valeant Pharmaceuticals, Stiefel Laboratories, Bayer AG, BioPharmX, Celtaxsys, Johnson & Johnson, Paratek Pharmaceuticals, Teva Pharmaceut

Acne Medication Market size was valued over USD 4.5 billion in 2017 and is expected to witness more than 6.5% CAGR from 2018 to 2024.

Increasing prevalence and severity of acne globally will drive the global market over the projection years. Acne vulgaris is the most common skin problem amongst the teenaged population, with women being affected at higher rates than men. According to the Global Burden of Disease study, acne vulgaris affects approximately 85% of young adults aged between 12–25 years.

Growing awareness regarding the acne treatment among the people living in the developing nation of Asia Pacific region will increase the sales of acne medication products. The people living in developing countries such as India, China, Taiwan and Thailand are now becoming more aware of the need to treat acne problems. Due to increase in awareness among the people regarding acne medication and its properties, there has been a high demand in the market for acne medication products, fueling the industry growth over the forecast period.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3010

The need of rigorous testing and follow-up for the use of prescribed isotretinoin will be one of the major market impeding factor. Stringent rules and regulations that are needed to follow while using the retinoids for acne medication will hamper the business growth in the forthcoming years.

Oral acne medication market is estimated to witness a considerable amount of growth at a CAGR of 6.9% over the projection period. Increase in number of persistent and severe cases of acne will result in growing demand and adoption rate of oral acne medication products as topical acne medication is not as effective as oral for the treatment of several types of acne blemishes.

Retinoids market held maximum market share in the year 2017 and was valued at around USD 1,299.9 million in the year 2017. Several advantages of using retinoids for acne treatment such as anti-aging, removal of dead skin cells, face cleansing and decreased post-inflammatory hyperpigmentation will be few of the major reasons for growing demand of acne medication products in the near future.

Prescription acne medication products are estimated to grow at a robust CAGR of 6.3% over the projection period. Increase in number of people suffering from severe acne problems that are not cured by OTC acne products will augment the growth of prescription acne products.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3010

The sale of acne medication among the people of age group 17-25 years was around USD 1,372.7 million in the year 2017. Excess skin oil and bacteria, improper food habits, hormonal changes and smoking are the major reasons for growing acne problems in the people aged between 17 and 25, thereby escalating the demand and boosting the acne medication market growth in the forthcoming years.

India acne medication market is projected to witness substantial growth at a CAGR of 9.2% over the forecast timeframe. According to a recent research survey, it was observed that the acne is one of the major skin problems in the school children. Along with increasing prevalence of acne in India, growing awareness among the people regarding the acne problems and the treatments associated with it will be one major market boosting factor.

Brazil dominated the Latin America acne medication market and was valued over USD 110.9 million in the year 2017. Growing prevalence of severe acne problems in the country along with increase in concern of the people towards facial aesthetics has resulted in boosting the demand and adoption rate of acne medication products, enhancing the industry growth in the Latin America region.

Prominent industry players include Allergan, Galderma, Valeant Pharmaceuticals, Bayer Healthcare, Johnson and Johnson and Teva Pharmaceuticals. The industry participants use strategies such as enhancing their manufacturing footprint, acquisition, new product launch and geographical expansion for improving their market position and competing with existing players to incur maximum sales and revenue.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary
2.1. Acne medication industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Formulation trends
2.1.3. Product trends
2.1.4. Type trends
2.1.5. Age group trends
2.1.6. Regional trends

Chapter 3. Acne Medication Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing prevalence of severe acne problems in North America
3.3.1.2. Growing awareness regarding the treatment options in Asia Pacific
3.3.1.3. Rising concern for facial aesthetics in Latin America
3.3.2. Industry pitfalls & challenges
3.3.2.1. Side-effects associated with acne medication
3.3.2.2. Entry of generic products
3.4. Growth potential analysis
3.4.1. By formulation
3.4.2. By product
3.4.3. By type
3.4.4. By age group
3.5. Regulatory Landscape
3.6. Global prevalence of acne, 2017
3.7. Porter’s analysis
3.8. Competitive landscape, 2017
3.8.1. Business overview
3.8.2. Revenue analysis
3.8.3. Product landscape
3.8.4. Strategy dashboard
3.9. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.